Insmed Inc (INSM) Stock Analysis

Insmed Inc (INSM) is a publicly traded company in the HEALTHCARE sector. It trades at $103.73, carries a market capitalization of $22.98B. This page summarizes the public market data, fundamentals, and frequently asked questions for INSM, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Insmed Inc currently has a Neutral sentiment score of -0.09.

About Insmed Inc

Insmed Inc. is a biopharmaceutical company headquartered in Bridgewater, New Jersey, dedicated to developing innovative therapies for rare and serious diseases, with a primary focus on pulmonary and infectious conditions. Its flagship product, ARIKAYCE, targets treatment-refractory Mycobacterium avium complex lung disease, addressing significant unmet medical needs in this area. With a strong commitment to research and development, Insmed is enhancing treatment options and health outcomes for...

GNG Research Analysis

GNG Research scores Insmed Inc (INSM) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for INSM.

Frequently Asked Questions

Does INSM pay dividends?

Insmed Inc (INSM) does not currently pay a regular dividend.

What is INSM's market cap?

Insmed Inc (INSM) has a market capitalization of $22.98B with a current stock price of $103.73.